Glenmark Pharmaceuticals receives revision in outlook on LT bank facilities

India Ratings and Research (Ind-Ra) has revised the Outlook on Glenmark Pharmaceuticals' (GPL) long-term bank facilities to Positive from Stable while affirming the ratings at IND AA. The rating on short-term bank facilities is reaffirmed at IND A1+.

Powered by Capital Market - Live News